Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




New Project to Expand Systems Biology Research

By LabMedica International staff writers
Posted on 03 Aug 2010
Advancing the study of systems biology is the object of a major Swiss interdisciplinary research consortium.

SystemsX.ch (Zurich, Switzerland) is currently the largest research initiative in Switzerland with the mandate to promote systems biology. More...
It is a consortium with nine universities and three research institutions as partners. The program is funded by the Swiss federal budget with matching funds paid by those partners receiving grants. The SystemsX.ch project currently supports about 750 researchers from 250 research groups in 62 approved projects. About half of the 250 research group leaders are biologists by training. The other half comprises chemists, physicists, engineers, computational scientists, medical scientists, mathematicians, and economists.

Two of the SystemsX.ch partners, AB SCIEX (Foster City, CA, USA) and the ETH Zurich Institute of Molecular Systems Biology (Zurich, Switzerland), recently announced a joint project to accelerate analysis and improve results for metabolomics.

Investigators at ETH will be using the AB SCIEX QTRAP 5500 System to develop a new method to reduce the time required for quantitative analysis of metabolites from approximately one hour to less than three minutes, while delivering comprehensive results. The QTRAP 5500 System is a mass spectrometry system that integrates triple quadrupole and linear accelerator trap technologies onto a single platform for faster and more accurate analysis of complex samples.

Dr. Uwe Sauerp, professor of systems biology at ETH Zurich Institute of Molecular Systems Biology, said, "Our partnering with AB SCIEX on new method development for metabolomics will drive the field of systems biology forward by addressing the need for more quantitative, comprehensive data that can be quickly obtained. The new method we are currently developing could be used for any analysis of any biological system. The AB SCIEX technology gives us unique capabilities to get the best possible data in the shortest period of time that we can apply to make a major difference in systems biology and biomedical research.”

Mr. Dave Hicks, a vice president at AB SCIEX, said, "Our project with ETH will help researchers make significant progress in metabolomics research more rapidly than was previously possible. This demonstrates how AB SCIEX mass spectrometry technology continues to advance life science by enabling new workflows that combine targeted and nontargeted analysis of the metabolome for a new approach to understand the role and impact of metabolites in biology.”

Related Links:
SystemsX.ch
AB SCIEX
ETH Zurich Institute of Molecular Systems Biology


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Manual Pipetting Aid
Pipette Controllers macro
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Study design and workflow (Parankusham H, Vanderlip C, Birkenbihl C, et al. A two-stage plasma biomarker algorithm reduces amyloid PET use and the p-Tau217 gray zone. Annals of Clinical and Translational Neurology. Published online October 19, 2026. doi:10.1002/acn3.70560)

Two-Step Blood Testing Approach Reduces Uncertainty in Amyloid Assessment

Blood-based biomarkers offer a more accessible, less expensive way to detect Alzheimer’s-related brain changes than traditional methods such as amyloid-beta positron emission tomography (Aβ-PET).... Read more

Molecular Diagnostics

view channel
Image: Tumor DNA is extracted from a pathology sample, and normal DNA is extracted from the buffy coat. Both samples undergo WGS to generate the patient-specific mutational signature. At each follow-up, ctDNA extracted from plasma undergoes WGS and is analyzed using a patient-derived signature and an artificial intelligence (AI) pattern recognition algorithm. FFPE: formalin fixed, paraffin embedded. (Snuderl M, Smadbeck J, Wilkins R, et al. The Journal of Molecular Diagnostics, 2026. DOI: 10.1016/j.jmoldx.2026.07.003)

Liquid Biopsy Detects Lung Cancer Recurrence Signals Months Before Imaging

Non-small cell lung cancer (NSCLC) is the most common type of lung cancer and remains a major cause of cancer-related death. Early-stage tumors are often treated surgically, but recurrence can still occur... Read more

Immunology

view channel
Image Credit: iStock

Antibody Profiling Predicts Inflammatory Bowel Disease Years Before Diagnosis

Inflammatory bowel disease (IBD), which includes Crohn’s disease and ulcerative colitis, involves abnormal immune responses that cause persistent inflammation and damage in the digestive system.... Read more

Pathology

view channel
Image: HETA Quality Control identifies slide quality issues before analysis, while HETA Tumor Detect annotates tumor regions and flags slides likely to contain tumor during scanning. (Photo courtesy of Aignostics)

AI Pathology Platform Targets Workflow Delays and Molecular Test Failures

Pathology laboratories often rely on visual review of tissue slides to assess quality, identify tumors, count mitoses, and estimate tumor content. These tasks can be time-consuming and vary between readers,... Read more

Technology

view channel
Image: Signals LabGistics uses AI to turn natural-language instructions and SOPs into coordinated scientific workflows, helping connect teams, systems, and processes. (Photo courtesy of Revvity)

New AI-Powered System Aims to Streamline Laboratory and Manufacturing Workflows

Scientific laboratories supporting drug development, biotechnology, and materials research increasingly rely on coordinated digital workflows to move data, samples, and activities across teams.... Read more

Industry

view channel
Image: The acquisition of Reveal Genomics would expand Hologic’s oncology diagnostics portfolio to support treatment decisions for more women with breast cancer.

Hologic to Broaden Breast Cancer Testing Portfolio Through Reveal Genomics Acquisition

Hologic (Marlborough, MA, USA) has signed a definitive agreement to acquire Reveal Genomics (Barcelona, Spain), a precision oncology company developing genomic diagnostic tests to help personalize cancer treatment.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.